Sam Jockel will speak on " Labeling-Focused Legislation and Regulation: Bioengineered (BE) Disclosure, Cannabis-Derived Ingredients, Plant-Based Foods, and More" at this conference sponsored by the Food and Drug Law Institute (FDLI).
Debate and public confusion abound about what manufacturers and retailers can and should say about the products we put into our bodies, often resulting in lengthy and time-consuming lawsuits or government actions. Join FDLI for this virtual conference to learn from and interact with leading practitioners and thought leaders in the food and dietary supplement industries, law firms, public health organizations, and regulatory agencies, all of whom will address the biggest issues and challenges in industry advertising, labeling, and litigation.
For more information or to register, click here.